Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
German A. Islan, Boris Rodenak-Kladniew, Nehuen Noacco, Nelson Duran & Guillermo R. Castro. (2022) Prodigiosin: a promising biomolecule with many potential biomedical applications. Bioengineered 13:6, pages 14227-14258.
Read now
Read now
Tadeusz Robak, Piotr Smolewski, Pawel Robak & Martin Dreyling. (2019) Mantle cell lymphoma: therapeutic options in transplant-ineligible patients. Leukemia & Lymphoma 60:11, pages 2622-2634.
Read now
Read now
Jung-Chen Su, Chuan-Hsun Chang, Szu-Hsien Wu & Chung-Wai Shiau. (2018) Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1. Journal of Enzyme Inhibition and Medicinal Chemistry 33:1, pages 1248-1255.
Read now
Read now
Jennifer R. Brown, Bethany Tesar, Lijian Yu, Lillian Werner, Naoko Takebe, Evgeny Mikler, Hazel M. Reynolds, Christina Thompson, David C. Fisher, Donna Neuberg & A. S. Freedman. (2015) Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia. Leukemia & Lymphoma 56:12, pages 3336-3342.
Read now
Read now
Morgane Cheminant, Stephen Robinson, Vincent Ribrag, Steven Le Gouill, Felipe Suarez, Richard Delarue & Olivier Hermine. (2015) Prognosis and outcome of stem cell transplantation for mantle cell lymphoma. Expert Review of Hematology 8:4, pages 493-504.
Read now
Read now
Elizabeth A. Brem & Matthew S. Davids. (2014) Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma?. Leukemia & Lymphoma 55:12, pages 2675-2677.
Read now
Read now
Articles from other publishers (32)
Amanda Reyes & Tanya Siddiqi. (2023) Targeting BCL2 pathways in CLL: a story of resistance and ingenuity. Cancer Drug Resistance 6:4, pages 828-37.
Crossref
Crossref
Noa Biran,Pooja Phull,andand & Andre Goy. 2023. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies
331
360
.
Yingtong Chen, Ping Yang, Jing Wang, Shuang Gao, Shiyu Xiao, Weilong Zhang, Mingxia Zhu, Yanfang Wang, Xiaoyan Ke & Hongmei Jing. (2023) p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma. Experimental Hematology & Oncology 12:1.
Crossref
Crossref
Puneet Singh & Bora Lim. (2022) Targeting Apoptosis in Cancer. Current Oncology Reports 24:3, pages 273-284.
Crossref
Crossref
Alakananda Basu. (2022) The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy. Pharmacology & Therapeutics 230, pages 107943.
Crossref
Crossref
Paul A. Townsend, Maria V. Kozhevnikova, Olivier N. F. Cexus, Andrey A. ZamyatninJrJr & Surinder M. Soond. (2021) BH3-mimetics: recent developments in cancer therapy. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Jingye Li, Jinrong Xu & Zhibing Li. (2021) Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade. Translational Oncology 14:8, pages 101116.
Crossref
Crossref
Linlin Zhang, Zaiming Lu & Xiangxuan Zhao. (2021) Targeting Bcl-2 for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188569.
Crossref
Crossref
Xiaye Lv, Yuting Jiang, Xinhui Wang, HaoQun Xie, Gaojing Dou, Jing Wang, Wenzhuo Yang, Hongyu Wang, Zijian Li, Xiangheng Zhang & Zhenghe Chen. (2021) Computational study on novel natural inhibitors targeting BCL2. Medical Oncology 38:8.
Crossref
Crossref
Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri & Martin Dreyling. (2020) Mantle cell lymphoma. Critical Reviews in Oncology/Hematology 153, pages 103038.
Crossref
Crossref
Magdalena Klanova & Pavel Klener. (2020) BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas. Cancers 12:4, pages 938.
Crossref
Crossref
Natalie Yan Li Ngoi, Clarice Choong, Joanne Lee, Gregory Bellot, Andrea LA Wong, Boon Cher Goh & Shazib Pervaiz. (2020) Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer. Cancers 12:3, pages 574.
Crossref
Crossref
Nikolay V. Pervushin, Viacheslav V. Senichkin, Boris Zhivotovsky & Gelina S. Kopeina. 2020. Cell Death Regulation in Health and Disease - Part A. Cell Death Regulation in Health and Disease - Part A
23
55
.
Maria Gonzalez-Santamarta, Grégoire Quinet, Diana Reyes-Garau, Brigitte Sola, Gaël Roué & Manuel S. Rodriguez. 2020. Proteostasis and Disease. Proteostasis and Disease
153
174
.
Mei Lan Tan, Shahrul Bariyah Sahul Hamid, Muhammad Asyraf Abduraman & Heng Kean Tan. 2020. Cancer Immunology. Cancer Immunology
307
353
.
Sonia Cournoyer, Anissa Addioui, Assila Belounis, Mona Beaunoyer, Carine Nyalendo, Roxane Le Gall, Pierre Teira, Elie Haddad, Gilles Vassal & Hervé Sartelet. (2019) GX15–070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma. BMC Cancer 19:1.
Crossref
Crossref
Zeping Han, Jiening Liang, Yuguang Li & Jinhua He. (2019) Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review. BioMed Research International 2019, pages 1-6.
Crossref
Crossref
Shu Yang, Yujia Mao, Huijun Zhang, Yan Xu, Jing An & Ziwei Huang. (2019) The chemical biology of apoptosis: Revisited after 17 years. European Journal of Medicinal Chemistry 177, pages 63-75.
Crossref
Crossref
Shengping Yu, Yang Liu, Zhen Zhang, Jingya Zhang & Guisen Zhao. (2019) Design, synthesis and biological evaluation of novel 2,3-indolinedione derivatives against mantle cell lymphoma. Bioorganic & Medicinal Chemistry 27:15, pages 3319-3327.
Crossref
Crossref
Lim, Greer, Lipkowitz & Takebe. (2019) Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox. Cancers 11:8, pages 1087.
Crossref
Crossref
Pawel Robak & Tadeusz Robak. (2019) Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later. Drugs in R&D 19:2, pages 73-92.
Crossref
Crossref
Sebastian Öther-Gee PohlMark AgostinoArun DharmarajanShazib Pervaiz. (2018) Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2. Antioxidants & Redox Signaling 29:13, pages 1215-1236.
Crossref
Crossref
Rebecca Valentin, Stephanie Grabow & Matthew S. Davids. (2018) The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood 132:12, pages 1248-1264.
Crossref
Crossref
Huanling Wu, L. Jeffrey Medeiros & Ken H. Young. (2018) Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances. Blood Reviews 32:1, pages 8-28.
Crossref
Crossref
Lindsey M. Ludwig, Michele L. Nassin, Abbas Hadji & James L. LaBelle. (2016) Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation. Frontiers in Pediatrics 4.
Crossref
Crossref
Arati A. Inamdar, Andre Goy, Nehad M. Ayoub, Christen Attia, Lucia Oton, Varun Taruvai, Mark Costales, Yu-Ting Lin, Andrew Pecora & K. Stephen Suh. (2016) Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget 7:30, pages 48692-48731.
Crossref
Crossref
Manoj Pandey, Sahdeo Prasad, Amit Tyagi, Lokesh Deb, Jiamin Huang, Deepkamal Karelia, Shantu Amin & Bharat Aggarwal. (2016) Targeting Cell Survival Proteins for Cancer Cell Death. Pharmaceuticals 9:1, pages 11.
Crossref
Crossref
Huansheng Fu, Xuben Hou, Lei Wang, Yanyan Dun, Xinying Yang & Hao Fang. (2015) Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 25:22, pages 5265-5269.
Crossref
Crossref
Tadeusz Robak. (2015) Bortezomib in the treatment of mantle cell lymphoma. Future Oncology 11:20, pages 2807-2818.
Crossref
Crossref
Irit Avivi & Andre Goy. (2015) Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice. Clinical Cancer Research 21:17, pages 3853-3861.
Crossref
Crossref
Laura Vela & Isabel Marzo. (2015) Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside. Current Opinion in Pharmacology 23, pages 74-81.
Crossref
Crossref
Yingtong Chen, Ping Yang, Jing Wang, Mingxia Zhu, Yanfang Wang, Shuang Gao, Weilong Zhang, Xiaoyan Ke & Hongmei Jing. (2022) p53 Directly Downregulates the Expression of CDC20 to Exert Anti-Tumor Activity in Mantle Cell Lymphoma. SSRN Electronic Journal.
Crossref
Crossref